Objectives: To explore the durability of three first-line tenofovir/emtricitabine-based regimens in combination with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in HIV-1-infected patients. Patients and methods: A retrospective, longitudinal, multicentre analysis of adult patients enrolled in the Antiretroviral Resistance Cohort...
-
2013 (v1)PublicationUploaded on: April 14, 2023
-
2019 (v1)PublicationPrevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients
No description
Uploaded on: April 14, 2023 -
2019 (v1)PublicationPrevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients
No description
Uploaded on: April 14, 2023 -
2018 (v1)Publication
Objectives: The aim was to evaluate the evolution of transmitted HIV-1 drug resistance (TDR) prevalence in antiretroviral therapy (ART)-naïve patients from 2006 to 2016. Methods: HIV-1 sequences were retrieved from the Antiviral Response Cohort Analysis (ARCA) database and TDR was defined as detection of at least one mutation from the World...
Uploaded on: April 14, 2023 -
2014 (v1)Publication
The factors influencing virological response to first-line combined antiretroviral therapy (cART) in an Italian cohort of HIV-1-infected patients were examined. Eligible patients were those enrolled in a national prospective observational cohort (Antiretroviral Resistance Cohort Analysis), starting first-line cART between 2001 and 2011 and who...
Uploaded on: April 14, 2023